We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$301M
AUM Growth
-$127M
Cap. Flow
-$134M
Cap. Flow %
-44.67%
Top 10 Hldgs %
57.1%
Holding
842
New
352
Increased
28
Reduced
90
Closed
287

Sector Composition

Rank Sector Weight
1 Healthcare 18.53%
2 Technology 13.41%
3 Financials 12.89%
4 Consumer Discretionary 7.02%
5 Industrials 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQMDW
676
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
-57,000
Closed -$5K
AMBC.WS
677
DELISTED
Ambac Financial Group
AMBC.WS
-82,842
Closed -$216K
BMAQW
678
DELISTED
Blockchain Moon Acquisition Corp. Warrants
BMAQW
$0 ﹤0.01%
15,331
TIOAW
679
DELISTED
Tio Tech A Warrants
TIOAW
-55,000
Closed -$4K
KALWW
680
DELISTED
Kalera Public Limited Company Warrant
KALWW
-28,000
Closed -$3K
TWNI.U
681
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
-38,202
Closed -$379K
LDHAW
682
DELISTED
LDH Growth Corp I Warrant
LDHAW
-56,500
Closed -$2K
GXIIW
683
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
-54,800
Closed -$5K
KSICW
684
DELISTED
Kadem Sustainable Impact Corporation Warrant
KSICW
$0 ﹤0.01%
10,808
FTPAW
685
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$0 ﹤0.01%
15,000
TBSAW
686
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
-50,200
Closed -$3K
AGGRW
687
DELISTED
Agile Growth Corp Warrant
AGGRW
$0 ﹤0.01%
11,400
-50,000
-81% -$1.06K
ACQRW
688
DELISTED
Independence Holdings Corp. Warrant
ACQRW
$0 ﹤0.01%
11,348
-50,000
-82% -$2.1K
ESM.WS
689
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
-58,290
Closed -$5K
IBER.WS
690
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$0 ﹤0.01%
11,625
-50,000
-81% -$1.57K
UMPQ
691
DELISTED
Umpqua Holdings Corp
UMPQ
-27,979
Closed -$478K
RNERW
692
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
-29,100
Closed -$4K
ABGI
693
DELISTED
ABG Acquisition Corp. I
ABGI
-27,649
Closed -$275K
ANAC.U
694
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
-23,761
Closed -$235K
FTAA
695
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
-25,133
Closed -$249K
LGACW
696
DELISTED
Lazard Growth Acquisition Corp. I Warrants
LGACW
$0 ﹤0.01%
14,365
-49,999
-78% -$1.33K
ITQRW
697
DELISTED
Itiquira Acquisition Corp. Warrant
ITQRW
$0 ﹤0.01%
50,000
WQGA.WS
698
DELISTED
World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WQGA.WS
$0 ﹤0.01%
46,100
-11,600
-20% -$310
SCOBW
699
DELISTED
ScION Tech Growth II Warrants
SCOBW
$0 ﹤0.01%
10,800
STOR
700
DELISTED
STORE Capital Corporation
STOR
-25,000
Closed -$783K

Similar funds

Alpine Global Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpine Global Management held 842 positions worth $301M, down 30% from $427M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Alpine Global Management withdrew a net $134M in Q4 2022, closing 287 positions and reducing 90 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $56.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Alpine Global Management opened a new position in Tesla worth $9.84M.

  • Alpine Global Management's largest Q4 2022 buy was Tesla: 79,871 shares worth $9.84M.
  • Alpine Global Management added most to Cornerstone Strategic Value Fund in Q4 2022, an estimated $9.51M increase.
  • Alpine Global Management's biggest Q4 2022 reduction was Immunovant, cutting an estimated $35.9M.
  • Alpine Global Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $56.5M.
  • Alpine Global Management's ten largest holdings make up 57% of its $301M portfolio in Q4 2022.
  • Alpine Global Management opened 352 new positions and closed 287 in Q4 2022.
  • Alpine Global Management's portfolio value fell 30% quarter-over-quarter to $301M.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.